Voyager Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.63M.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $3.04M.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $19.30M, a 37.97% decline year-over-year.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $31.12M.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $31.12M.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2017 was $57.99M.
- Voyager Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2015 was $72.95M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.63M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.04M 10-Q · filed 2026-08-06 | |
| 2024-03-31 | $19.30M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $31.12M 10-K · filed 2024-02-28 | |
| 2023-03-31 | $31.12M 10-Q · filed 2023-11-06 | |
| 2017-12-31 | $57.99M 10-K · filed 2020-03-03 | |
| 2015-12-31 | $72.95M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |